Company Overview

Update
Founded:
2003
Headquarters:
Washington D.c., DC
IPO:
Went Public on Aug 7, 2013
Stock:
NASDAQ:VNDA
Categories:
Biotechnology

Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the

Description

Update

Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.

Current Team (5)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    2200 Pennsylvania Ave NW

    Suite 300E

    Washington D.c., DC 20037

    USA

Images (1)

Update
  • 80cf27baeca3f455a1991e41c68556c8